Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'
Clinical trial NCT02677493 · COMPLETED
Trial details
- NCT number
- NCT02677493
- Sponsor
- Il-Yang Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 1794
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.